Company intelligence / Profile preview

Enzyre

Nijmegen, Gelderland, Netherlandsenzyre.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Enzyre has developed the ENZYSYSTEM, a near-patient diagnostic platform enabling real-time blood coagulation analysis using microfluidic cartridges and chemiluminescent detection. The system allows up to sixteen simultaneous reactions from a small blood sample, providing rapid results to patients and clinicians outside of traditional laboratory settings. The company recently closed a €12M Series A round to advance clinical validation for hemophilia applications. Clinical results are not yet published but the technology has been validated in pre-commercial settings.

Therapeutic areas: Hematology
Modalities: DeviceDiagnostic platform (microfluidic cartridge-based)Chemiluminescent assay technology
Industry: Protein Biomarker Diagnostics

Partnerships

Takeda Ventures (strategic investor/partner)

Beyond the preview

Go deeper on Enzyre.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enzyre.

Explore the full profile